BOSTON SCIENTIFIC CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BOSTON SCIENTIFIC CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $9.08B | Feb 23, 2017 |
| FY2016 | Dec 31, 2015 | $8.07B | Feb 23, 2017 |
| FY2016 | Dec 31, 2014 | $7.46B | Feb 23, 2017 |
| FY2015 | Dec 31, 2013 | $7.07B | Feb 24, 2016 |
| FY2014 | Dec 31, 2012 | $6.96B | Feb 25, 2015 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.07B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $16.75B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $14.24B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $12.68B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $11.89B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $9.91B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $10.74B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $9.82B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $9.05B | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $8.39B | Feb 19, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $9.05B | Feb 20, 2018 |
| FY2017 | Dec 31, 2016 | $8.39B | Feb 20, 2018 |
| FY2017 | Dec 31, 2015 | $7.48B | Feb 20, 2018 |
| FY2016 | Dec 31, 2014 | $7.38B | Feb 23, 2017 |
| FY2015 | Dec 31, 2013 | $7.14B | Feb 24, 2016 |
| FY2014 | Dec 31, 2012 | $7.25B | Feb 25, 2015 |
| FY2013 | Dec 31, 2011 | $7.62B | Feb 26, 2014 |
| FY2010 | Dec 31, 2010 | $2.00B | Feb 17, 2011 |
| FY2010 | Sep 30, 2010 | $1.92B | Feb 17, 2011 |
| FY2010 | Jun 30, 2010 | $1.93B | Feb 17, 2011 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.85B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $11.49B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $9.90B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $8.73B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $8.18B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $6.45B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $7.62B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $7.01B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $6.46B | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $5.96B | Feb 19, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.61B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $2.60B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $2.34B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $1.65B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $1.20B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | ($80.00M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.52B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $1.51B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $1.29B | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $447.00M | Feb 19, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.89B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $5.98B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $5.19B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $4.52B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $4.36B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $3.79B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $3.94B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $3.57B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $3.29B | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $3.10B | Feb 19, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.53B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $3.44B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $2.50B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $1.53B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $1.87B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $1.51B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.84B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $310.00M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $1.43B | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $1.18B | Feb 19, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $876.00M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $790.00M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $711.00M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $588.00M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $554.00M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $376.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $461.00M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $316.00M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $319.00M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $376.00M | Feb 19, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $43.67B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $39.40B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $35.14B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $32.47B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $32.23B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $30.78B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $30.57B | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $21.00B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $19.04B | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $18.10B | Feb 20, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.23B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $21.77B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $19.28B | Feb 18, 2025 |
| FY2024 | Dec 31, 2022 | $17.57B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $16.62B | Feb 20, 2024 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.28B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $17.09B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $14.39B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $12.92B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $11.99B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $9.95B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $10.18B | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $7.91B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $7.00B | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $6.68B | Feb 19, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.57B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $2.67B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $819.00M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | ($750.00M) | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | ($1.39B) | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | ($2.38B) | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | ($2.25B) | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | ($6.95B) | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | ($8.39B) | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | ($8.58B) | Feb 20, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.97B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $414.00M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $865.00M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $928.00M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $1.93B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $1.73B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $217.00M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $146.00M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $188.00M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $196.00M | Feb 19, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $3.82B | Feb 20, 2018 |
| FY2017 | Dec 31, 2016 | $5.42B | Feb 20, 2018 |
| FY2015 | Dec 31, 2015 | $5.65B | Feb 24, 2016 |
| FY2014 | Dec 31, 2014 | $4.20B | Feb 25, 2015 |
| FY2013 | Dec 31, 2013 | $4.20B | Feb 26, 2014 |
| FY2012 | Dec 31, 2012 | $4.20B | Feb 22, 2013 |
| FY2011 | Dec 31, 2011 | $4.20B | Feb 17, 2012 |
| FY2010 | Dec 31, 2010 | $5.45B | Feb 17, 2011 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | 3 | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Feb 19, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | 3 | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Feb 19, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | 1.39B | Feb 25, 2020 |
| FY2019 | Dec 31, 2018 | 1.38B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | 1.37B | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | 1.36B | Feb 20, 2018 |
| FY2016 | Dec 31, 2015 | 1.35B | Feb 23, 2017 |
| FY2015 | Dec 31, 2014 | 1.33B | Feb 24, 2016 |
| FY2014 | Dec 31, 2013 | 1.32B | Feb 25, 2015 |
| FY2013 | Dec 31, 2012 | 1.36B | Feb 26, 2014 |
| FY2012 | Dec 31, 2011 | 1.45B | Feb 22, 2013 |
| FY2011 | Dec 31, 2010 | 1.52B | Feb 17, 2012 |